ATI - Advanced Medical Technologies

Advanced Medical Technologies (ATI) develops medical devices for the ophthalmology market. Its products are designed to significantly improve the patients experience during diagnostic procedures while also increasing efficiency. The companys flagship product, Field-Induced Mydriasis (FIM), is a pupil-dilation device. The device dramatically improves the examination experience by achieving full dilation within 90 to 120 seconds, with full recovery within minutes. FIM is a safe, non-contact, drug-free, and CE-approved device. ATI is currently developing a personal ocular tonometer called NIT. This device will be used by the patients themselves to measure their intraocular pressure for the early detection of glaucoma.

ATI - Advanced Medical Technologies was founded in 2005 by Tomas Mendelsohn (Board Director & CEO), Abraham Livne (late) (Founder), Ilan Ron (Founder & VP R&D).

ATI - Advanced Medical Technologies operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, with core technologies in Platforms & Interfaces, Software, Simulation & Imaging. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.

ATI - Advanced Medical Technologies is based in HaYetsira 11b, Ra'anana, Israel, Center District.